Palisade Bio jumps following Oppenheimer outperform initiation
Seeking Alpha ·
Oppenheimer has initiated Palisade Bio ( PALI ) at outperforming, sending the stock ~14% higher in Thursday morning trading. The investment bank has an $8 price target (321% upside based on July 22 close). Analyst Lelend Gershell sees strong potential in PALI-2108, which
DYAX Investor Sentiment
Bullish (Long) 47% · Bearish (Short) 53%
483 participants
Related News
- WTI crude will near $115/bbl by the end of 2026 – Kalshi
- Huhtamäki Oyj 1H non-GAAP EPS of EUR 0.89, revenue of EUR 1.96B
- PG&E’s data center project pipeline more than doubled in Q2
- Conventum - Alluvium Global Fund adds CPRT
- Elon Musk and Tesla's next big engineering challenge? Thumbs.
- Supermicro's massive $60B backlog likely requires financing: Mizuho
